Lucyd, Inc
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Lucyd, Inc's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Shareholder Slice Ratio: Share count rose 1,400% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than 91% of Healthcare companies in United States.
- Cash Locked Ratio: For every $100 of sales, $46 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $46 from others' credit three years earlier. More money tied up than 90% of Healthcare companies in United States.
- Growth Efficiency Ratio: Sales grew 303% in 3 years, but profit fell: $95 less profit per $100 of extra sales. Lower than 86% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-25.7×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 61% of Healthcare companies in United States.
Cash Locked Ratio
$46For every $100 of sales, $46 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $46 from others' credit three years earlier.
More money tied up than 90% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 1/3Sales grew in 3 of the last 3 years; profit grew in 1 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
−$95Sales grew 303% in 3 years, but profit fell: $95 less profit per $100 of extra sales.
Lower than 86% of Healthcare companies in United States.
Asset Productivity Ratio
+303% / +116%In 3 years sales changed by +303% while total assets changed by +116%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
—Data incomplete
Tangible Assets Ratio
94%Of every $100 the company owns, $94 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 70% of Healthcare companies in United States.
Tangible Net Worth Ratio
94%Of every $100 of net worth, $94 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 78% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
Lucyd, Inc made a loss over the last year. Lucyd, Inc owes $0.08 for every $1 it owns. Lucyd, Inc made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossLucyd, Inc made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.09The share price is 1.09 times Lucyd, Inc's book value per share, lower than 77% of Healthcare companies in United States.
Market cap
$8 MThe total market value of all of Lucyd, Inc's shares at today's price (share price × number of shares), smaller than 90% of Healthcare companies in United States. PosiCap size class: Nano Cap.
Net worth (book value)
$7 MWhat Lucyd, Inc would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.79Net worth divided by the number of shares. The share price of $0.86 is 1.1 times this, which is the P/B above.
Return on equity (ROE)
-84.6%Lucyd, Inc lost 84.6% of its shareholders' money over the last year, lower than 67% of Healthcare companies in United States.
Owes vs Owns
0.08×Lucyd, Inc owes $0.08 for every $1 it owns (low), lower than 91% of Healthcare companies in United States.
Dividend yield
NoneLucyd, Inc does not currently pay a dividend.
Revenue growth
+63%Revenue rose 63% in the year to Dec 2025, and grew 59% a year on average over 3 years.
Profit growth
LossLucyd, Inc made a loss in each of the last two years.
Profit margin
-285.2%Lucyd, Inc lost $285 for every $100 of revenue.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Lucyd, Inc: $8 M ÷ $7 M (30 Jun 2026) = 1.1.
What is Lucyd, Inc's return on equity?
Lucyd, Inc lost 84.6% of its shareholders' money over the last year, lower than 67% of Healthcare companies in United States.
How much does Lucyd, Inc owe compared with what it owns?
Lucyd, Inc owes $0.08 for every $1 it owns (low), lower than 91% of Healthcare companies in United States.
Does Lucyd, Inc pay a dividend?
No. Lucyd, Inc does not currently pay a dividend.
Is Lucyd, Inc's revenue growing?
Revenue rose 63% in the year to Dec 2025, and grew 59% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.